Search Results - "Galve, E"

P006 Randomized Phase II trial evaluating three anti-diarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06) by González-Santiago, S., Gil-Gil, M., Carrasco, E., Martínez-Jáñez, N., Adamo, B., Antolín, S., Alonso, J.L., Vethencourt, A., Martínez-Vila, C., Galve, E., Rojo, F., Caballero, R., Casas, M., Cortazar, E., McCulloch, L., Vedovato, J.-C., Martín, M.

Get full text

Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study by Galve, Enrique, Sambola, Antonia, Saldaña, Germán, Quispe, Iván, Nieto, Elsa, Diaz, Anna, Evangelista, Arturo, Candell-Riera, Jaume

“…To examine the mid-term and long-term outcomes in patients with obstructive hypertrophic cardiomyopathy (HCM) submitted to pacing. Prospective, observational…”
Get more information

2147 Pathological response as a prognostic factor for disease free survival on colorectal cancer with liver limited disease by Vicente, B.L. San, Nieto, J, Arbide, N, Perez-Hoyos, M.T, Arrazubi, V, Arevalo, A, Arango, J, Zumarraga, A, Fernandez, S, Sala, M.A, Galve, E, Novas, P, Sande, L, Abad, T, Prado, P Martinez del

Get full text

1918 Impact of an osteoporosis unit in the incidence of fractures in early breast cancer patients with aromatase inhibitors by Novas Vidal, P, Fernandez, S, Galve, E, Arrazubi, V, Sala, M.A, Torre, I, Arevalo, A, Arango, J.F, López de San Vicente, B, Pérez, C, Zumárraga, A, Abad, M.T, Garcia, M.L, Marínez, M.P

Get full text

Worldwide perspective of valve disease by Soler-Soler, Jordi, Galve, Enrique

“…[...]valve replacement accounts for the majority of cardiac surgery in these countries. [...]systemic lupus is a complex disease in which multiple…”
Get full text

399 Trend in a Satisfaction Test in Chemotherapy Day Clinic Patients by del Prado, P. Martinez, Utrera, M, Pérez-Hoyos, M.T, Sande, L, Arrazubi, V, Sala, M.A, Gutierrez, M, Antonilli, C, Galve, E

Get full text

Position statement of the SEMI, SED, redGDPS, SEC, SEEDO, SEEN, SEMERGEN y SEMFYC by Gómez Huelgas, R, Gómez Peralta, F, Carrillo Fernández, L, Galve, E, Casanueva, F F, Puig Domingo, M, Mediavilla Bravo, J J, Orozco Beltrán, D, Muñoz, J Ena, Menéndez Torre, E, Artola Menendez, S, Mazón Ramos, P, Monereo Megías, S, Caixas Pedrágos, A, López Simarro, F, Álvarez Guisasola, F

Get full text

5022 POSTER DISCUSSION Association Between Circulating Tumour Cells and Bone Turnover Markers in Patients With Breast Cancer and Bone Metastases on Treatment With Bisphosphonates (ZOMAR Study) by Manso, L, Tusquets, I, De la Piedra, C, Crespo, C, Gomez, P, Calvo, L, Galve, E, Borrego, M. Ruiz, Rifá, J, Barnadas, A

Get full text

First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN by Martínez-Jañez, N., Ezquerra, M. Bellet, Manso Sanchez, L. M., Carrasco, F. Henao, Torres, A. Anton, Morales, S., Ortega, P. Tolosa, Gil, V. L. Obadia, Sampedro, T., Conejero, R. Andrés, Calvo-Martinez, L., Galve-Calvo, E., López, R., de la Pena, F. Ayala, Lopez-Tarruella, S., de Araguiz, B. A. Hernando Fernandez, Ruiz, L. Boronat, Cardenas, T. Martos, Chacon, J. I., Antón, F. Moreno

“…Purpose To evaluate the efficacy and safety of first-line therapy with palbociclib in a Spanish cohort treated after palbociclib approval. Methods PALBOSPAIN…”
Get full text

Cambiando el paradigma: valsartán-inhibidor de la neprilisina, nuevo fármaco dual para la hipertensión arterial y la insuficiencia cardíaca by Galve, E, Casas-Masnou, G, García-Dorado, D

Get full text

Consenso de médicos expertos en HTA sobre el uso clínico de la triple terapia antihipertensiva a dosis fija en España by Mazón, P, Galve, E, Gómez, J, Gorostidi, M, Górriz, J.L, Mediavilla, J.D

“…Resumen Introducción La opinión de expertos (de distintas especialidades) sobre la triple terapia antihipertensiva a dosis fijas en la práctica clínica puede…”
Get full text

Surgery of the primary tumor for de novo metastatic breast cancer: The controversy continues by López de San Vicente, B., Galve Calvo, E., Zumarraga, A., Pikab ea, F., Arango Arteaga, J.F., López Santillan, M., Figaredo, C., Sala Gonzalez, M.A., Nuño Escolastico, M., Novas Vidal, P., Legaspi, J., Martinez del Prado, P.

Get full text

Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer by Ayala de la Peña, F., Ortiz-Muñoz, B., Quintanar-Verdúguez, T., Santotoribio, J. D., de la Cruz, S., Trapé-Pujol, J., Galve-Calvo, E., Augé-Fradera, J. M., García-Gómez, J., González-Hernández, Á.

“…The measurement of circulating tumour markers (TMs) for the diagnosis or monitoring of breast cancer has sometimes been considered of limited utility. In…”
Get full text

Management of patients with metastatic breast cancer by Cruz Jurado, Josefina, Richart Aznar, Paula, García Mata, Jesus, Fernández Martínez, Roberto, Peláez Fernández, Ignacio, Sampedro Gimeno, Teresa, Galve Calvo, Elena, Murillo Jaso, Laura, Polo Marqués, Eduardo, García Palomo, Andrés

“…Hormone treatment is one of the key strategies in the management of metastatic breast cancer. Hormone treatment is one of the key strategies in the management…”
Get full text

QT dispersion after myocardial infarction with heart failure: additional prognostic marker? by Soler-Soler, J, Galve, E

Get full text

A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy by VILLARD, Eric, PERRET, Claire, DUBOURG, Olivier, TAVAZZI, Luigi, AUMONT, Marie-Claude, DEGROOTE, Pascal, FAUCHIER, Laurent, TROCHU, Jean-Noël, GIBELIN, Pierre, AUPETIT, Jean-François, STARK, Klaus, ERDMANN, Jeanette, GARY, Françoise, HETZER, Roland, ROBERT, Angharad M, BARTON, Paul J. R, REGITZ-ZAGROSEK, Vera, ASLAM, Uzma, DUBOSCQ-BIDOT, Laëtitia, MEYBORG, Matthias, MAISCH, Bernhard, MADEIRA, Hugo, WALDENSTRÖM, Anders, PROUST, Carole, GALVE, Enrique, CLELAND, John G, DORENT, Richard, ROIZES, Gerard, ZELLER, Tanja, BLANKENBERG, Stefan, GOODALL, Alison H, COOK, Stuart, TREGOUET, David A, TIRET, Laurence, DITANIAN, Gilles, ISNARD, Richard, KOMAJDA, Michel, CHARRON, Philippe, CAMBIEN, François, HENGSTENBERG, Christian, RUPPERT, Volker, ARBUSTINI, Eloisa, WICHTER, Thomas, GERMAIN, Marine

“…Dilated cardiomyopathy (DCM) is a major cause of heart failure with a high familial recurrence risk. So far, the genetics of DCM remains largely unresolved. We…”
Get full text

P6265Prevalence of clinical features of familial hypercholesterolemia in patients admitted for an acute coronary syndrome by Cordero, A, Facila, L, Castro, A, Lidon, R M, Nunez, J, Galve, E, Gonzalez-Juanatey, J R

Get full text

P6412Prognostic impact of atrial fibrillation in patients with chronic stable coronary heart disease by Cordero, A, Rodriguez-Manero, M, Castellano, J M, Facila, L, Bertomeu-Gonzalez, V, Otero, F, Lado, M, Allut, G, Galve, E, Gonzalez-Juanatey, J R

Get full text

129TiP Metformin (MF) in the prevention of hyperglycemia (HG) in patients (pts) with PIK3CA-mutated, hormone receptor (HR)[+]/HER2[–] advanced breast cancer (ABC) treated with alpelisib (ALP) plus fulvestrant (F): METALLICA by Llombart Cussac, A., Pérez-Garcia, J.M., Blanch, S., Tolosa, P., Ruiz Borrego, M., Gion Cortes, M., Fernádez, A., Urruticoechea, A., Galve, E., Cueva Banuelos, J.F., Ponce, J., Alonso, J.L., Capelán, M., Martínez, E., Bermejo De Las Heras, B., Rojas, B., Martos, T., López, A., Gómez-Peralta, F., Cortés, J.

Get full text

A multicomponent exercise intervention to prevent functional decline in older patients with cancer: a pilot study by Lopez de San Vicente Hernandez, B., García-García, J., Basterretxea, L., Casado, G., Arrieta, H., Aurtenetxe, A., Gomez-Mediavilla, J., Perez-Hoyos, M.T., Pelaez, M., Galve, E., Irazusta, J., Martinez del Prado, P., Rodriguez-Larrad, A.

Get full text